Pharma

Your Article Summary

See Latest Articles

ImmunoGen, Inc. Reports First Quarter Fiscal Year 2010 Financial Results
ImmunoGen, Inc., 10/30/09

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload technology, announced financial results for the three–month period ended September, 2009 – the first quarter of the Company’s 2010 fiscal year (1QFY10).

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

See All of Financial Reports